Australia markets open in 6 hours 12 minutes

Kiromic BioPharma, Inc. (5JU0.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
4.09950.0000 (0.00%)
As of 03:56PM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 424.80k
Enterprise value 7.37M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)9.69
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.26

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 31,270.30%
S&P500 52-week change 327.84%
52-week high 36.9000
52-week low 30.1300
50-day moving average 33.6450
200-day moving average 33.1225

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 51.18M
Implied shares outstanding 61.18M
Float 8963.16k
% held by insiders 118.90%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 313 Mar 2023

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-98.48%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -18.05M
Net income avi to common (ttm)-24.35M
Diluted EPS (ttm)-52.4900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.68M
Total cash per share (mrq)2.82
Total debt (mrq)13.58M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.29
Book value per share (mrq)-5.53

Cash flow statement

Operating cash flow (ttm)-22.8M
Levered free cash flow (ttm)-15.57M